Last reviewed · How we verify
NCT03998605: AP4ID
Protect Yourself: Abuse Prevention for People With Intellectual Disabilities
NA trial testing Abuse Prevention Program in Abuse Prevention. Withdrawn.
30 November 2022
Quick facts
| Lead sponsor | Double S Instructonal Systems |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Start date | 4 October 2022 |
| Primary completion | 30 November 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Abuse Prevention Program
- Control Condition
Conditions studied
- Abuse Prevention — all drugs for Abuse Prevention →
Sponsor
Double S Instructonal Systems
Who can join
18 and older, any sex, with Abuse Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to help individuals and their caregivers develop a plan on how to recognize, deal with and respond to abusive situations.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03998605
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03998605 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Double S Instructonal Systems
- Last refreshed: 15 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03998605.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing